文献速递细菌感染、耐药与抗菌药物医院感染防控

抗菌药物使用的驱动因素:跨机构、利益相关者与经济环境的定性多中心研究

The drivers of antimicrobial use across institutions, stakeholders and economic settings: a paradigm shift is required for effective optimization.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

该研究在澳大利亚5家医院对222名医生、护士、药师和管理者进行半结构化访谈与主题分析,识别出社会关系与机构结构两类影响抗菌药物使用的因素。作者认为抗菌药物优化策略需同时纳入个人、人际与机构变量,而非仅关注处方行为改进。

要点

  • 社会关系因素包括个人风险感知、层级、专业内外互动及对抗菌药物耐药长期改变的无力感。
  • 机构结构因素包括患者人群特征(社会经济、地理隔离、局部感染模式)及邻近性与资源问题。
  • 抗菌药物优化需多层级干预,仅针对个体处方行为改进不足。

核心结论

  • 抗菌药物优化成功取决于充分认识并整合多层级影响因素。
  • 需要范式转变,将个人、人际和机构变量纳入优化策略。

研究设计与样本

  • 定性多中心设计,在澳大利亚5家医院(4家公立:2家都市、1家区域、1家偏远;1家私立)开展222次半结构化访谈。
  • 参与者包括85名医生、79名护士、31名药师和27名医院管理者,采用主题分析。

主要发现

  • 识别出跨环境的社会关系影响抗菌药物使用,包括个人风险、层级、专业间与专业内动态及长期改变耐药的无望感。
  • 识别出机构结构提供情境特异性影响,包括患者人群因素(社会经济因素、地理隔离、局部感染模式)及邻近性与资源问题。

临床怎么用

  • 抗菌药物管理应同时评估并干预社会关系与机构结构因素,而非仅聚焦处方者个体行为。
  • 优化策略需结合当地患者人群特征、地理与资源条件设计多层级干预。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Significant antimicrobial overuse persists worldwide, despite overwhelming evidence of antimicrobial resistance and knowledge that optimization of antimicrobial use will slow the development of resistance. It is critical to understand why this occurs. This study aims to consider the social influences on antimicrobial use within hospitals in Australia, via an in-depth, multisite analysis. METHODS: We used a qualitative multisite design, involving 222 individual semi-structured interviews and thematic analysis. Participants (85 doctors, 79 nurses, 31 pharmacists and 27 hospital managers) were recruited from five hospitals in Australia, including four public hospitals (two metropolitan, one regional and one remote) and one private hospital. RESULTS: Analysis of the interviews identified social relationships and institutional structures that may have a strong influence on antimicrobial use, which must be addressed concurrently. (i) Social relationships that exist across settings: these include the influence of personal risk, hierarchies, inter- and intraprofessional dynamics and sense of futility in making a difference long term in relation to antimicrobial resistance. (ii) Institutional structures that offer context-specific influences: these include patient population factors (including socioeconomic factors, geographical isolation and local infection patterns), proximity and resource issues. CONCLUSIONS: The success of antimicrobial optimization rests on adequate awareness and incorporation of multilevel influences. Analysis of the problem has tended to emphasize individual 'behaviour improvement' in prescribing rather than incorporating the problem of overuse as inherently multidimensional and necessarily incorporating personal, interpersonal and institutional variables. A paradigm shift is urgently needed to incorporate these critical factors in antimicrobial optimization strategies.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Broom J, Broom A, Kirby E, et al. The drivers of antimicrobial use across institutions, stakeholders and economic settings: a paradigm shift is required for effective optimization. J Antimicrob Chemother. 2019. PMID: 31169902. doi:10.1093/jac/dkz233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。